Healthcare provider profile · identity verified

Izabela Riffe, MD

Family Practice · JACKSONVILLE, FL · NPI 1225027188

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	304	113
Rosuvastatin Calcium	Rosuvastatin Calcium	242	82
Atorvastatin Calcium	Atorvastatin Calcium	231	91
Lisinopril	Lisinopril	172	68
Levothyroxine Sodium	Levothyroxine Sodium	166	65
Losartan Potassium	Losartan Potassium	147	53
Metoprolol Succinate	Metoprolol Succinate	114	44
Tramadol Hcl	Tramadol Hcl	112	25
Hydrochlorothiazide	Hydrochlorothiazide	111	41
Alprazolam	Alprazolam	107	30
Omeprazole	Omeprazole	93	41
Ozempic	Semaglutide	88	13
Pantoprazole Sodium	Pantoprazole Sodium	83	32
Zolpidem Tartrate	Zolpidem Tartrate	72	20
Tamsulosin Hcl	Tamsulosin Hcl	68	25
Eliquis	Apixaban	67	21
Gabapentin	Gabapentin	67	26
Pravastatin Sodium	Pravastatin Sodium	63	20
Prednisone	Prednisone	63	38
Escitalopram Oxalate	Escitalopram Oxalate	57	23
Simvastatin	Simvastatin	53	21
Ezetimibe	Ezetimibe	47	19
Furosemide	Furosemide	46	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	12
Trazodone Hcl	Trazodone Hcl	44	19
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Metformin Hcl	Metformin Hcl	42	19
Sertraline Hcl	Sertraline Hcl	41	18
Carvedilol	Carvedilol	40	14
Allopurinol	Allopurinol	39	18
Lorazepam	Lorazepam	38	suppressed
Meloxicam	Meloxicam	36	16
Montelukast Sodium	Montelukast Sodium	33	13
Diazepam	Diazepam	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	14
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	13
Metformin Hcl Er	Metformin Hcl	30	12
Famotidine	Famotidine	28	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Potassium Chloride	Potassium Chloride	26	11
Synthroid	Levothyroxine Sodium	25	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Naproxen	Naproxen	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Azithromycin	Azithromycin	22	20
Spironolactone	Spironolactone	22	12
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Cephalexin	Cephalexin	20	14
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	12
Xarelto	Rivaroxaban	20	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Estradiol	Estradiol	19	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	12
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	18	17
Finasteride	Finasteride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Bupropion Xl	Bupropion Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Torsemide	Torsemide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Atenolol	Atenolol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error